Home›Search›Cancer Nanotechnology

Cancer Nanotechnology

Springer Science + Business Media · United States · Est. 2007

ISSN1868-6958eISSN1868-6966

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

101

days submission → published

measured · last 19 articles · accept 73d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.849

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.742

Total Worksi

426

Total Citationsi

9,832

2yr Mean Citednessi

6.15

Open Impact Factor alternative

Aims & Scope

Journal information Electronic ISSN 1868-6966 Print ISSN 1868-6958 Abstracted and indexed in Baidu CLOCKSS CNKI CNPIEC Chemical Abstracts Service (CAS) Chinese Academy of Medical Science (CAMS) DOAJ Dimensions EBSCO EMBASE GoOA - The Chinese Academy of Sciences (CAS) Google Scholar INIS Atomindex Japanese Science and Technology Agency (JST) Naver OCLC WorldCat Discovery Service Ovid Discovery Portico ProQuest Reaxys SCImago SCOPUS Science Citation Index Expanded (SCIE) Semantic Scholar TD Net Discovery Service Wanfang eLibrary.ru © Springer-Verlag GmbH Austria, part of Springer Nature

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2007

Annual Volume~ 68 articles / year

StatusActive (last: 2026)

Total Publications426

Publisher OrgBioMed Central

OA Since2009

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~15 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoKoninklijke Bibliotheek; Library of Congress; National Science Library, Chinese Academy of SciencesCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Springer Science + Business Media

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1868-6958 / 1868-6966

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, Koninklijke Bibliotheek; Library of Congress; National Science Library, Chinese Academy of Sciences, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

755

2019

463

2020

2021

722

2022

1.3k

2023

745

2024

278

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmaceutical ScienceQ1

Physical and Theoretical ChemistryQ1

Biomedical EngineeringQ2

OncologyQ2

Subject Classification

Web of Science Categories

Nanoscience & NanotechnologyOncology

Scopus Categories

Biomedical EngineeringPhysical and Theoretical ChemistryPharmaceutical ScienceOncology

Research Topics (OpenAlex)

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryGraphene and Nanomaterials ApplicationsAdvanced biosensing and bioanalysis techniquesRadiation Therapy and DosimetryNanoparticles: synthesis and applicationsAdvanced Nanomaterials in CatalysisExtracellular vesicles in diseaseMicroRNA in disease regulation

Frequently asked questions about Cancer Nanotechnology

Is Cancer Nanotechnology a predatory journal?

PubScope has no integrity flags on record for Cancer Nanotechnology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Nanotechnology?

Cancer Nanotechnology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.15.

Is Cancer Nanotechnology indexed in Scopus and Web of Science?

Cancer Nanotechnology is indexed in Web of Science, Scopus, DOAJ.